| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7504495 | Drug and Alcohol Dependence | 2015 | 8 Pages |
Abstract
The present subchronic treatment results support the utility of preclinical methamphetamine choice to evaluate candidate medications for methamphetamine addiction. Furthermore, these results confirm and extend previous results demonstrating differential pharmacological mechanisms between cocaine choice and methamphetamine choice.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kathryn L. Schwienteck, Matthew L. Banks,